Trending in Altmetric
This article is in the top 10% of similar research outputs scored by Altmetric,
a service which tracks the online attention articles have received.
McMaster PLUS Selected
This article has been identified as especially clinically relevant or newsworthy by at least 3
practicing clinicians and of high scientific quality by expert researchers
as a part of the McMaster PLUS article rating service.
AbstractText: Mailed fecal immunochemical test (FIT) outreach is more effective than colonoscopy outreach for increasing 1-time colorectal cancer (CRC) screening, but long-term effectiveness may need repeat testing and timely follow-up for abnormal results AbstractText: Compare the effectiveness of FIT outreach and colonoscopy outreach to increase completion of ...
... like receptor protein 3 (NLRP3) inflammasome with canakinumab might alter cancerincidence AbstractText: We did a randomised, double-blind, placebo-controlled trial ... Participants were followed up for incidentcancer diagnoses, which were adjudicated by an oncology endpoint committee masked ... targeting the interleukin-1β innate immunity pathway could significantly reduce incident lung cancer and lung cancer mortality.
AbstractText: The ERSPC (European Randomized Study of Screening for Prostate Cancer) found that screening reduced prostate cancer mortality, but the PLCO (Prostate, Lung, Colorectal, and Ovarian CancerScreening Trial) found no reduction AbstractText: To evaluate whether effects of screening on prostate cancer mortality relative to no screening differed between the ERSPC and PLCO AbstractText: Cox regression of ... or 55 to 74 (PLCO) years at randomization AbstractText: Prostate cancerscreening AbstractText: Prostate cancerincidence and survival from randomization; prostate cancerincidence in the United States before screening began AbstractText: Estimated MLTs ...
Abstract: This year's Lasker-DeBakey Prize for Clinical Research to Douglas Lowy and John Schiller celebrates the science behind one of the greatest advances in the history of cancer research: the development of vaccines that prevent infection and thus preventtumor induction by pathogenic strains of human papilloma virus (HPV.